ArticleBMC psychiatry2020

Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study.

Akira Iwanami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.